Arnaud Lacoste, PhD

The chief scientific officer of Aurion Biotech discussed the properties of the cell therapy for corneal dystrophies, which was recently approved in Japan.

The chief scientific officer of Aurion Biotech discussed the investigational cell therapy AURN001.